YU121389A - Derivatives of benzazepine and benzothiazepine - Google Patents

Derivatives of benzazepine and benzothiazepine

Info

Publication number
YU121389A
YU121389A YU01213/89A YU121389A YU121389A YU 121389 A YU121389 A YU 121389A YU 01213/89 A YU01213/89 A YU 01213/89A YU 121389 A YU121389 A YU 121389A YU 121389 A YU121389 A YU 121389A
Authority
YU
Yugoslavia
Prior art keywords
benzothiazepine
benzazepine
derivatives
Prior art date
Application number
YU01213/89A
Other languages
English (en)
Inventor
D Floyd
J T Hunt
S D Kimball
J Krapcho
J Das
G C Rovnyak
J C Barrish
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of YU121389A publication Critical patent/YU121389A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
YU01213/89A 1988-06-20 1989-06-14 Derivatives of benzazepine and benzothiazepine YU121389A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives

Publications (1)

Publication Number Publication Date
YU121389A true YU121389A (en) 1991-04-30

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01213/89A YU121389A (en) 1988-06-20 1989-06-14 Derivatives of benzazepine and benzothiazepine

Country Status (29)

Country Link
US (1) US4902684A (fr)
JP (1) JP2793674B2 (fr)
KR (1) KR970002633B1 (fr)
CN (1) CN1027262C (fr)
AT (1) AT398567B (fr)
AU (1) AU614399B2 (fr)
BE (1) BE1003305A4 (fr)
CA (1) CA1336975C (fr)
CH (1) CH681723A5 (fr)
EG (1) EG19071A (fr)
ES (1) ES2016467A6 (fr)
FI (1) FI94246C (fr)
FR (1) FR2632953B1 (fr)
GB (1) GB2231329B (fr)
GR (1) GR1002099B (fr)
HU (1) HU210929B (fr)
IE (1) IE64242B1 (fr)
IL (1) IL90515A (fr)
IT (1) IT1230884B (fr)
LU (1) LU87865A1 (fr)
NL (1) NL8920642A (fr)
NO (1) NO179449C (fr)
NZ (1) NZ229612A (fr)
PL (1) PL162313B1 (fr)
PT (1) PT90914B (fr)
RU (1) RU2090562C1 (fr)
SE (1) SE9004060L (fr)
WO (1) WO1989012633A1 (fr)
YU (1) YU121389A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
ATE228115T1 (de) * 1991-06-28 2002-12-15 Smithkline Beecham Corp Bizyklische fibrinogenantagonisten
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (fr) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines et 2,5-dihydro-2-oxo-1h-azepines et leur utilisation comme antagonistes des recepteurs de l'acide amine excitateur et de la glycine
WO1995002405A1 (fr) * 1993-07-16 1995-01-26 Merck & Co., Inc. Benzoxasinone et benzopyrimidinone piperidinyle utiles comme antagonistes tocolytiques du recepteur de l'oxytocine
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
ATE246927T1 (de) * 1994-03-24 2003-08-15 Merrell Pharma Inc Cholesterin senkende mercaptoacetylamiddisulfidderivate
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
KR100472154B1 (ko) * 1996-12-10 2005-02-21 아보트 러보러터리즈 3-피리딜 에난티오머
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
ES2367258T3 (es) * 2002-04-19 2011-10-31 Arizona Board Of Regents On Behalf Of The University Of Arizona Métodos para modular la fototoxicidad.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747C (fr) * 1985-06-12 1990-07-17 Derives de benzazepines
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748A (fr) * 1985-12-12 1990-07-17 Jagabandhu Das Derives de benzazepine
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
ATE64925T1 (de) * 1986-08-20 1991-07-15 Mcneilab Inc Benzothiazepin-vasodilatoren mit aralkylsubstitution.
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
GB9002587D0 (en) 1990-08-29
NO179449C (no) 1996-10-09
KR970002633B1 (en) 1997-03-06
HUT59908A (en) 1992-07-28
JPH04502002A (ja) 1992-04-09
CA1336975C (fr) 1995-09-12
FI94246B (fi) 1995-04-28
NL8920642A (nl) 1990-06-01
PT90914B (pt) 1994-12-30
HU894298D0 (en) 1991-01-28
LU87865A1 (de) 1991-12-16
NZ229612A (en) 1992-07-28
GR1002099B (en) 1995-12-28
GR890100410A (el) 1990-05-11
IL90515A0 (en) 1990-01-18
ATA901089A (de) 1994-05-15
AT398567B (de) 1994-12-27
CN1027262C (zh) 1995-01-04
AU3859389A (en) 1990-01-12
WO1989012633A1 (fr) 1989-12-28
KR920700207A (ko) 1992-02-19
NO905485L (no) 1991-02-19
EG19071A (en) 1994-07-30
FR2632953B1 (fr) 1992-05-29
NO905485D0 (no) 1990-12-19
PT90914A (pt) 1989-12-29
IT1230884B (it) 1991-11-08
AU614399B2 (en) 1991-08-29
SE9004060L (sv) 1992-06-20
US4902684A (en) 1990-02-20
IE64242B1 (en) 1995-07-26
CN1039585A (zh) 1990-02-14
RU2090562C1 (ru) 1997-09-20
JP2793674B2 (ja) 1998-09-03
FI94246C (fi) 1995-08-10
NO179449B (no) 1996-07-01
FR2632953A1 (fr) 1989-12-22
FI900813A0 (fi) 1990-02-19
IE891957L (en) 1989-12-20
HU210929B (en) 1995-09-28
SE9004060D0 (sv) 1990-12-19
CH681723A5 (fr) 1993-05-14
PL162313B1 (pl) 1993-09-30
GB2231329B (en) 1992-10-21
ES2016467A6 (es) 1990-11-01
BE1003305A4 (fr) 1992-02-25
GB2231329A (en) 1990-11-14
IL90515A (en) 1994-07-31
IT8920933A0 (it) 1989-06-20

Similar Documents

Publication Publication Date Title
ZA908446B (en) Use of a benzodiazepine and phenylpyrrylketone derivative
YU121389A (en) Derivatives of benzazepine and benzothiazepine
IL92622A0 (en) Production and use of porphyrins
GB2333292B (en) Derivatives of hexaazoisowurtzitane
NZ216416A (en) Benzazepine derivatives and pharmaceutical compositions
ZA898741B (en) Use of azepinone derivatives
HRP931011A2 (en) Benzothiazepine and benzoxazepine derivatives
ZA902150B (en) Benzazepine and benzothiazepine derivatives
ZA892089B (en) Cephalosporin derivatives and processes for their preparation
AU6558990A (en) Use of a benzodiazepine and a phenylpyrrylketone derivative
NZ229751A (en) Azacyclohexyl derivatives of rifamycin and pharmaceutical compositions
ZA894315B (en) Benzazepine and benzothiazepine derivatives
EP0486727A3 (en) Microbial reduction of benzazepine and benzothiazepine derivatives
AU3502189A (en) Use of diazepinones
HK1003571A1 (en) Alkenyltetrazole derivatives their preparation and use
DE3990664T1 (de) Benzazepin- und benzothiazepin-derivate
IL83193A0 (en) Cephalosporins and derivatives
IE893670L (en) Use of azepinone derivatives
IL92606A0 (en) Sphingenine and derivatives thereof
DK296790A (da) Benzazepin- og benzothiazepinderivater
ZA875511B (en) Cephalosporins and derivatives
IE881760L (en) Derivatives of n-phenylpyrazoles
CS521788A1 (en) Derivatives of trimethoprine
YU11688A (en) Derivatives of pyridazodiazepine
ZA894427B (en) Benzazepine derivatives